Brian M. Stuglik, Director at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 9,900 shares at $3.39 ($34K) on 2024-06-13, disclosed to the SEC on 2024-06-17.
Scheduled sale ($34k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VSTM | SELL | 2025-09-18 | $6K | — | Filing → |
| VSTM | SELL | 2025-06-20 | $3K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $27K | — | Filing → |